Economic evaluation of the Akwenda Intervention Program for children and young people with cerebral palsy in rural Uganda: A trial-based analysis of costs and outcomes.
Elizabeth Asige, Eric Kintu, Gillian Saloojee, Godfrey Wanjala, Carin Andrews, Lukia H Namaganda, Angelina Kakooza-Mwesige, Diane L Damiano, Hans Forssberg
{"title":"Economic evaluation of the Akwenda Intervention Program for children and young people with cerebral palsy in rural Uganda: A trial-based analysis of costs and outcomes.","authors":"Elizabeth Asige, Eric Kintu, Gillian Saloojee, Godfrey Wanjala, Carin Andrews, Lukia H Namaganda, Angelina Kakooza-Mwesige, Diane L Damiano, Hans Forssberg","doi":"10.1111/dmcn.70581","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To relate the trial-based costs of the Akwenda Intervention Program, a multi-component, community-based intervention for children and young people with cerebral palsy (CP) in rural Uganda, to multiple prespecified child and caregiver outcomes.</p><p><strong>Method: </strong>An economic evaluation was conducted within a cluster-randomized, assessor-blinded trial of 94 participants with CP (aged 2-23 years; 42 females) and their caregivers, allocated to intervention or usual care. Programme delivery costs were assessed from a restricted health care or provider perspective; selected out-of-pocket costs incurred by participating families were reported separately over 12 months. Outcome-specific incremental cost-effectiveness ratios (ICERs) were estimated for child outcomes (66-item Gross Motor Function Measure, Pediatric Evaluation of Disability Inventory [Ugandan version], and Picture My Participation) and caregiver outcomes (Zimbabwe Caregiver Challenges Scale and Pediatric Quality of Life Inventory Family Impact Module). Uncertainty was assessed using bootstrapping, cost-effectiveness planes, and exploratory acceptability curves. Costs were also determined per minimal clinically important difference (MCID) gained.</p><p><strong>Results: </strong>The mean incremental cost per child was US$1069 to US$1075. Outcome-specific ICERs ranged from US$26 to US$352 per unit of improvement for 10 of 11 outcomes; the Pediatric Evaluation of Disability Inventory (Ugandan version) mobility had a higher and highly uncertain ICER. Costs per MCID gained ranged from US$230 to US$600. Acceptability analyses were presented as exploratory uncertainty analyses because no established Uganda-specific willingness-to-pay thresholds exist for these outcome measures.</p><p><strong>Interpretation: </strong>The Akwenda Intervention Program improved child functioning, participation, and caregiver well-being at additional but predictable costs. This trial-based economic evaluation quantifies the costs associated with improvement across multiple prespecified outcomes and provides economic information relevant to the implementation of community-based rehabilitation in low-resource settings.</p>","PeriodicalId":50587,"journal":{"name":"Developmental Medicine and Child Neurology","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2026-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Developmental Medicine and Child Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dmcn.70581","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Aim: To relate the trial-based costs of the Akwenda Intervention Program, a multi-component, community-based intervention for children and young people with cerebral palsy (CP) in rural Uganda, to multiple prespecified child and caregiver outcomes.
Method: An economic evaluation was conducted within a cluster-randomized, assessor-blinded trial of 94 participants with CP (aged 2-23 years; 42 females) and their caregivers, allocated to intervention or usual care. Programme delivery costs were assessed from a restricted health care or provider perspective; selected out-of-pocket costs incurred by participating families were reported separately over 12 months. Outcome-specific incremental cost-effectiveness ratios (ICERs) were estimated for child outcomes (66-item Gross Motor Function Measure, Pediatric Evaluation of Disability Inventory [Ugandan version], and Picture My Participation) and caregiver outcomes (Zimbabwe Caregiver Challenges Scale and Pediatric Quality of Life Inventory Family Impact Module). Uncertainty was assessed using bootstrapping, cost-effectiveness planes, and exploratory acceptability curves. Costs were also determined per minimal clinically important difference (MCID) gained.
Results: The mean incremental cost per child was US$1069 to US$1075. Outcome-specific ICERs ranged from US$26 to US$352 per unit of improvement for 10 of 11 outcomes; the Pediatric Evaluation of Disability Inventory (Ugandan version) mobility had a higher and highly uncertain ICER. Costs per MCID gained ranged from US$230 to US$600. Acceptability analyses were presented as exploratory uncertainty analyses because no established Uganda-specific willingness-to-pay thresholds exist for these outcome measures.
Interpretation: The Akwenda Intervention Program improved child functioning, participation, and caregiver well-being at additional but predictable costs. This trial-based economic evaluation quantifies the costs associated with improvement across multiple prespecified outcomes and provides economic information relevant to the implementation of community-based rehabilitation in low-resource settings.
期刊介绍:
Wiley-Blackwell is pleased to publish Developmental Medicine & Child Neurology (DMCN), a Mac Keith Press publication and official journal of the American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) and the British Paediatric Neurology Association (BPNA).
For over 50 years, DMCN has defined the field of paediatric neurology and neurodisability and is one of the world’s leading journals in the whole field of paediatrics. DMCN disseminates a range of information worldwide to improve the lives of disabled children and their families. The high quality of published articles is maintained by expert review, including independent statistical assessment, before acceptance.